Revvity Inc (BSP:R1VT34)
R$ 23.77 0 (0%) Market Cap: 81.00 Bil Enterprise Value: 93.46 Bil PE Ratio: 56.19 PB Ratio: 1.79 GF Score: 65/100

PerkinElmer Inc at Stifel Healthcare Conference Transcript

Nov 16, 2022 / 02:10PM GMT
Release Date Price: R$23.21
Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst

Okay. Welcome everybody. We are on the Life Sciences track of the Stifel Healthcare Conference here. I am here with Maxwell Krakowiak, CFO of PerkinElmer. Max, thanks for joining us here today.

Maxwell Krakowiak
PerkinElmer, Inc. - Senior VP & CFO

Thanks for having me Dan.

Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst

Yes. For sure. You took the job 4 months ago as far as the CFO, but you have been at the company for about 4 years if I am getting that right. I'd like to just sort of ask how it's going.

Maxwell Krakowiak
PerkinElmer, Inc. - Senior VP & CFO

-It's going good. It's been a lot of fun so far. We got a couple of things going on a little bit, but it's busy, but it's been good.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot